Skip to main content

Closed

INAB: IN8bio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-76.2%

Financially safe

Stretched

Debt / equity0.10×

Interest coverage0.0×

Current ratio10.50×

IN8bio, Inc.

INABNASDAQ Global Market·USD·Closed

IN8bio, Inc.

INABNASDAQ·USD·Closed

$1.03

−4.17%

$1.03

−$0.05 (4.17%)

52W Range

4thpctl

Volume

1.04×avg

Mkt Cap

9.93MUSD

P/E

-0.3TTM

Div Yield

–ann

52W Range

4thpctl

Volume

1.04×avg

Market Cap

9.93MUSD

P/E Ratio

-0.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings